Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
The mean duration of GLP-1RAs treatment ranged from 4 and 12 months
You can read the abstract of this article at In the SURPASS-4 trial, the dual GIP and GLP-1 receptor agonist tirzepatide demonstrated superior reductions in HbA1c concentrations, bodyweight, and blood pressure compared to titrated daily insulin glargine in individuals with type 2 diabetes and cardiovascular risk
GLP-1 meds are life-changing
This research peptide is supplied with batch-level analytical documentation, secure checkout and pan-India dispatch within 48 hours
US$ 28.76
US$ 23.48
US$ 29.93
US$ 26.08
